(3S,4S)-N-[2-(diethylsulfamoyl)ethyl]-4-methyl-1-([1,2,4]triazolo[4,3-a]pyrazin-8-yl)pyrrolidine-3-carboxamide
C17H27N7O3S — CID 124742116
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S,4S)-N-[2-(diethylsulfamoyl)ethyl]-4-methyl-1-([1,2,4]triazolo[4,3-a]pyrazin-8-yl)pyrrolidine-3-carboxamide
(3S,4S)-N-[2-(diethylsulfamoyl)ethyl]-4-methyl-1-([1,2,4]triazolo[4,3-a]pyrazin-8-yl)pyrrolidine-3-carboxamide (PubChem CID 124742116) has the molecular formula C17H27N7O3S and a molecular weight of 409.52 g/mol. Its IUPAC name is (3S,4S)-N-[2-(diethylsulfamoyl)ethyl]-4-methyl-1-([1,2,4]triazolo[4,3-a]pyrazin-8-yl)pyrrolidine-3-carboxamide.
Molecular Properties
| Compound Name | (3S,4S)-N-[2-(diethylsulfamoyl)ethyl]-4-methyl-1-([1,2,4]triazolo[4,3-a]pyrazin-8-yl)pyrrolidine-3-carboxamide |
|---|---|
| PubChem CID | 124742116 |
| Molecular Formula | C17H27N7O3S |
| Molecular Weight | 409.52 g/mol |
| Exact Mass | 409.19 |
| IUPAC Name | (3S,4S)-N-[2-(diethylsulfamoyl)ethyl]-4-methyl-1-([1,2,4]triazolo[4,3-a]pyrazin-8-yl)pyrrolidine-3-carboxamide |
| SMILES | CCN(CC)S(=O)(=O)CCNC(=O)[C@@H]1CN(c2nccn3cnnc23)C[C@H]1C |
| InChI | InChI=1S/C17H27N7O3S/c1-4-24(5-2)28(26,27)9-7-19-17(25)14-11-23(10-13(14)3)15-16-21-20-12-22(16)8-6-18-15/h6,8,12-14H,4-5,7,9-11H2,1-3H3,(H,19,25)/t13-,14-/m1/s1 |
| InChIKey | XEQNIFAEDPTOGI-ZIAGYGMSSA-N |
| XLogP | -0.02 |
| TPSA | 112.80 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 409.52 |
| LogP ≤ 5 | -0.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 124742116 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.